Résultats de la recherche

Cytrellis Secures Health Canada and Saudi Food and Drug Authority Approval for ellacor® with Micro-Coring® Technology Cytrellis Biosystems has received approval to commercialize its groundbreaking ellacor® with Micro-Coring® technology in Canada and Saudi Arabia.

Cytrellis’ Next-Generation ellacor® Optimizes Micro-Coring for Enhanced Patient and Provider Experience Cytrellis' next-generation ellacor® system with Micro-Coring® enhances patient and provider experience. It will be showcased at industry conferences.

Cytrellis Biosystems launches Updated Next-Generation Skin Removal Treatment ellacor® 2.0, fueled by new leadership and financing Cytrellis marks new era of growth with the launch of ellacor 2.0, fueled by the completion of new financing and theappointment of Dr. Denise Dajles as CEO.